Search Orphan Drug Designations and Approvals
-
Generic Name: | otelixizumab |
---|---|
Date Designated: | 02/06/2006 |
Orphan Designation: | Treatment of new-onset type I diabetes mellitus |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 07/22/2020 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
GlaxoSmithKline 2301 Renaissance Blvd (RN0420) P. O. Box 61540 King of Prussia, Pennsylvania 19406 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-